This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This initiative was born out of a council meeting of the Asian Network of BipolarDisorder (ANBD) in 2013, at which Prof. Pichet Udomratn proposed a date to bring worldwide attention to bipolardisorder. To register your activities and share event details, please visit: [link]. Together, we can make a difference.
One of many psychiatrists exposed by 2008 Congressional hearings on psychiatry’s financial relationship with drug companies was Harvard psychiatrist Joseph Biederman—credited with creating pediatric bipolardisorder—who received $1.6 million in consulting fees from drug makers from 2000 to 2007.
For a period of four years, from 2014 through 2018 during his decline and overwhelm, Matt was prescribed five different antidepressants layered on top of one another without tapering, which ignited a cycle of adverse reactions. Thankfully, the owner of the office, a renowned bipolar expert, said he could take Matt. It was just so sad.
To clarify this concept better, “psychosis”, “depression”, “anxiety”, “bipolardisorder”, “ADHD” and more are not disorders of organic or genetic origin, caused by “imbalances” in brain chemicals, and psychotropic drugs do not have the function of restoring any balance.
In 2014, the Danish Ministry of Health issued a licence to kill. Depressive and bipolardisorders: patients attitudes and beliefs towards depression and antidepressants. 29 Forbruget af antipsykotika blandt 18-64 rige patienter, med skizofreni, mani eller bipolar affektiv sindslidelse. 30 This is as mad as it gets.
This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray).
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content